{"id":23655,"date":"2025-04-13T17:40:11","date_gmt":"2025-04-13T17:40:11","guid":{"rendered":"https:\/\/researchchemicalstore.eu\/?post_type=product&p=23655"},"modified":"2025-10-22T14:57:47","modified_gmt":"2025-10-22T14:57:47","slug":"idra-21-10-mg-pellets","status":"publish","type":"product","link":"https:\/\/researchchemicalstore.eu\/da\/vare\/idra-21-10-mg-pellets\/","title":{"rendered":"IDRA-21 10 MG Pellets"},"content":{"rendered":"

IDRA-21 10 MG Pellets \u2013 Videnskabelig beskrivelse og brugermanual<\/span><\/span><\/strong><\/h3>\n

Produktbeskrivelse<\/span><\/span><\/strong><\/h4>\n

IDRA-21 (10 mg pellets)<\/span><\/span><\/strong> \u00a0er et potentiale\u00a0 <\/span><\/span>AMPA-receptorpotentiator<\/span><\/span><\/strong> \u00a0tilh\u00f8rer klassen af\u00a0 <\/span><\/span>nootropiske og neurobeskyttende forskningskemikalier<\/span><\/span><\/strong> . Det virker ved at forst\u00e6rke glutamatinduceret signalering i hjernen, hvilket kan f\u00f8re til forbedret kognitiv funktion, neuroplasticitet og potentielt neurorecovery.<\/span><\/span><\/p>\n

Disse pellets er\u00a0 <\/span><\/span>meget ren (\u226598%)<\/span><\/span><\/strong> , standardiseret dosering og udelukkende beregnet til\u00a0 <\/span><\/span>videnskabelig forskning og pr\u00e6kliniske studier<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n

\n

Anvendelser og anvendelser<\/span><\/span><\/strong><\/h3>\n

IDRA-21 unders\u00f8ges for dets mulige virkninger p\u00e5:<\/span><\/span><\/p>\n

    \n
  1. \n

    Kognitiv forbedring<\/span><\/span><\/strong> \u00a0\u2013 Kan \u00f8ge \u00e5rv\u00e5genhed, indl\u00e6ringsevne og hukommelseskonsolidering.<\/span><\/span><\/p>\n<\/li>\n

  2. \n

    Neurobeskyttelse<\/span><\/span><\/strong> \u00a0\u2013 Potentiel beskyttende effekt ved neurodegenerative sygdomme (f.eks. Alzheimers, slagtilf\u00e6lde).<\/span><\/span><\/p>\n<\/li>\n

  3. \n

    Neurologisk genopretning<\/span><\/span><\/strong> \u00a0\u2013 Kan fremme synaptisk plasticitet efter hjerneskade.<\/span><\/span><\/p>\n<\/li>\n

  4. \n

    Videnskabelig forskning<\/span><\/span><\/strong> \u00a0\u2013 Unders\u00f8gelse af AMPA-receptormodulation og glutamatsignalering.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

    \u26a0\u00a0Ikke godkendt til human eller veterin\u00e6r brug \u2013 Kun til in vitro og kontrollerede pr\u00e6kliniske studier.<\/span><\/span><\/strong><\/p>\n

    \n

    Dosering og sikkerhedsretningslinjer<\/span><\/span><\/strong><\/h3>\n
      \n
    • \n

      Unders\u00f8gelsesdosis (in vitro\/pr\u00e6klinisk): <\/span><\/span><\/strong>\u00a05\u201320 mg\/kg<\/span><\/span><\/strong> \u00a0(afh\u00e6ngigt af modellen).<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Pelletl\u00f8sning:<\/span><\/span><\/strong> \u00a0Kan opl\u00f8ses i\u00a0 <\/span><\/span>destilleret vand eller DMSO<\/span><\/span><\/strong> \u00a0til eksperimenter.<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Administration:<\/span><\/span><\/strong> \u00a0Oralt (dyremodeller) eller direkte i cellekulturer.<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Frekvens:<\/span><\/span><\/strong> \u00a0Enkelt dosis ved akut effekt; langtidsstudier kr\u00e6ver omhyggelig overv\u00e5gning.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

      \ud83d\udea8\u00a0NB:<\/span><\/span><\/strong><\/p>\n

        \n
      • \n

        Ingen menneskelig anvendelse<\/span><\/span><\/strong> \u00a0\u2013 Ingen sikkerhedsdata til human brug.<\/span><\/span><\/p>\n<\/li>\n

      • \n

        H\u00f8je doser kan for\u00e5rsage neuroexcitotoksicitet.<\/span><\/span><\/strong><\/p>\n<\/li>\n

      • \n

        Undg\u00e5 kombination med andre glutamatmodulatorer.<\/span><\/span><\/strong><\/p>\n<\/li>\n<\/ul>\n

        \n

        Ulemper og risici<\/span><\/span><\/strong><\/h3>\n
          \n
        • \n

          Overstimulering af neuroner<\/span><\/span><\/strong> \u00a0(risiko for excitotoksicitet i tilf\u00e6lde af overdosis).<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Mulig angst eller agitation<\/span><\/span><\/strong> \u00a0i modtagelige modeller.<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Begr\u00e6nsede langsigtede data<\/span><\/span><\/strong> \u00a0om tolerance og bivirkninger.<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Ikke egnet til kronisk brug<\/span><\/span><\/strong> \u00a0uden omfattende toksicitetsunders\u00f8gelser.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

          \n

          Ofte stillede sp\u00f8rgsm\u00e5l (FAQ)<\/span><\/span><\/strong><\/h3>\n

          1. Er IDRA-21 lovligt i Holland?<\/span><\/span><\/strong><\/h4>\n

          Ja, men kun til\u00a0 <\/span><\/span>videnskabelig forskning<\/span><\/span><\/strong> . Det falder ikke ind under opiumloven, men det er heller ikke godkendt som medicin.<\/span><\/span><\/p>\n

          2. Hvordan virker IDRA-21 pr\u00e6cist?<\/span><\/span><\/strong><\/h4>\n

          Det\u00a0 <\/span><\/span>forst\u00e6rker AMPA-receptorresponset<\/span><\/span><\/strong> , hvilket g\u00f8r glutamatsignalering l\u00e6ngere og mere intens. Dette kan f\u00f8re til forbedret synaptisk kommunikation.<\/span><\/span><\/p>\n

          3. Kan IDRA-21 sammenlignes med andre nootropika?<\/span><\/span><\/strong><\/h4>\n

          Den har en unik virkningsmekanisme, men\u00a0 <\/span><\/span>lignende m\u00e5l som racetam eller ampakiner<\/span><\/span><\/strong> \u00a0(f.eks. Sunifiram).<\/span><\/span><\/p>\n

          4. Er der nogen kendte interaktioner?<\/span><\/span><\/strong><\/h4>\n
            \n
          • \n

            NMDA-antagonister<\/span><\/span><\/strong> \u00a0(f.eks. memantin) \u2013 Potentielt bivirkninger.<\/span><\/span><\/p>\n<\/li>\n

          • \n

            GABAerge midler<\/span><\/span><\/strong> \u00a0(f.eks. benzodiazepiner) \u2013 Kan reducere den angstd\u00e6mpende virkning.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

            \n

            Laboratorierapport og kvalitetskontrol<\/span><\/span><\/strong><\/h3>\n
              \n
            • \n

              HPLC-analyse: <\/span><\/span><\/strong>\u00a0\u226598% renhed<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n<\/li>\n

            • \n

              Ingen p\u00e5viselige tungmetaller eller opl\u00f8sningsmiddelrester<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n<\/li>\n

            • \n

              Homogen pelletformulering<\/span><\/span><\/strong> \u00a0for ensartet dosering.<\/span><\/span><\/p>\n<\/li>\n

            • \n

              Batchcertificering<\/span><\/span><\/strong> \u00a0til r\u00e5dighed for forskningsinstitutioner.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

              \n

              Anbefalede forskningsscenarier<\/span><\/span><\/strong><\/h3>\n
                \n
              1. \n

                Kognitive studier<\/span><\/span><\/strong> \u00a0\u2013 Effekter p\u00e5 hukommelse og indl\u00e6ring i dyremodeller.<\/span><\/span><\/p>\n<\/li>\n

              2. \n

                Neurobeskyttende forskning<\/span><\/span><\/strong> \u00a0\u2013 Potentiel rolle i isk\u00e6misk skade (slagtilf\u00e6ldemodeller).<\/span><\/span><\/p>\n<\/li>\n

              3. \n

                Elektrofysiologi<\/span><\/span><\/strong> \u00a0\u2013 M\u00e5linger af AMPA-receptorrespons i neuronale kulturer.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

                \ud83d\udd2c\u00a0Kun til kontrolleret laboratoriebrug \u2013 Ingen rekreativ brug!<\/span><\/span><\/strong><\/p>\n

                ","protected":false},"excerpt":{"rendered":"

                IDRA-21 Pellets egenskaber<\/span><\/span><\/h3>\n

                Synonym<\/span><\/span><\/strong> 7-chlor-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazin-1,1-dioxid <\/span><\/span>
                \nCAS <\/span><\/span><\/strong> Antal<\/span><\/span><\/strong> : 22503-72-6 <\/span><\/span>
                \nFormel<\/span><\/span><\/strong> C8H9ClN2O2S <\/span><\/span>
                \nMol\u00e6r masse<\/span><\/span><\/strong> : 232,6 g\/mol <\/span><\/span>
                \nRenhed<\/span><\/span><\/strong> : >97%<\/span><\/span><\/p>","protected":false},"featured_media":28802,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[548,549,330,324],"product_tag":[326],"class_list":{"0":"post-23655","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-idra-21","7":"product_cat-idra-21-pellets","8":"product_cat-nootropics","9":"product_cat-pellets-for-pellet","10":"product_tag-nl","12":"first","13":"instock","14":"taxable","15":"shipping-taxable","16":"purchasable","17":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product\/23655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/comments?post=23655"}],"version-history":[{"count":5,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product\/23655\/revisions"}],"predecessor-version":[{"id":28058,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product\/23655\/revisions\/28058"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/media\/28802"}],"wp:attachment":[{"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/media?parent=23655"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product_brand?post=23655"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product_cat?post=23655"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/da\/wp-json\/wp\/v2\/product_tag?post=23655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}